	Progressive orexin A positive neuron loss in the 6-OHDA mouse model of Parkinson's disease: a pilot study with validation of an orexin A immunohistochemistry protocol for paraffin-embedded tissue. Brain Res Braun A, Vo PT, Bobrovskaya L. PMID: 42323123 [PubMed - as supplied by publisher]
	Corrigendum to "Large-scale profiling of blood microbial signatures in patients with Parkinson's disease and its association with disease progression: a cross-sectional study" [EBioMedicine 126(2026) 106224]. EBioMedicine Jian X, Yu P, Zhang Y, Pan H, Wu K, Zhang H, Zhang H, Huang Y, Zhao Y, Wang Y, Wang Y, Zhou Q, Zhang X, Zhao G, Li B, Guo J, Xia K, Tang B, Li J. PMID: 42322852 [PubMed - as supplied by publisher]
	Identification of natural MAO-B inhibitors with enhanced binding and dynamic stability: Implications for Parkinson's disease therapy. Comput Biol Chem Sayadi M, Ramazani A, Zarei A. PMID: 42322787 [PubMed - as supplied by publisher]
	An exploratory (18)F-Florzolotau tau PET study in putative body-first versus brain-first Parkinson's disease. Eur J Nucl Med Mol Imaging Xu C, Jiao F, Ni Y, Xu Z, Hu T, Li S, Li X, Liang X, Wang J, Zuo C, Tang Y. PMID: 42322399 [PubMed - as supplied by publisher]
	Observational Retrospective Cohort of Patient Support Program Data on Practical Experiences of Treatment with Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: The ORCHESTRA Study. Neurol Ther Warnecke T, Van der Plas AA, Schwingenschuh P, Johansson A, Simu M, O'Meara M, Gupta R, Fritz B, Bergmann L, Parra JC, Südmeyer M. PMID: 42322391 [PubMed - as supplied by publisher]
	The role of dynamic Lowenstein occupational therapy and cognitive assessment scale for the elderly with Parkinson's disease. BMC Geriatr Yaman F, Ar, Soylu EA, Pek, Leblebicier MA, Özlü A, Gökp, Yenen B, Kavuncu V. PMID: 42321630 [PubMed - as supplied by publisher]
	Recombinant GBA1 alleles presenting as exon-level deletions by short-read NGS in Parkinson disease: Implications for diagnostic approaches. J Hum Genet Hong YJ, Jang MA, Yang D, Kim JW, Youn J, Cho JW, Jang JH. PMID: 42321433 [PubMed - as supplied by publisher]
	Synthesis, biological evaluation and in silico studies of novel propargyl-tethered isatin hydrazones as monoamine oxidase inhibitors for Parkinson's disease. Sci Rep Parmbil SK, Kim HJ, Lim J, Abdelgawad MA, Abdel-Bakky MS, Ghoneim MM, Vishwakarma HC, Kumar S, Kumar S, Kim H, Mathew B. PMID: 42321329 [PubMed - as supplied by publisher]
	Auditory cueing modulates motor performance and brain activity in early Parkinson's disease-a kinematic and fMRI study. NPJ Parkinsons Dis Gardoni A, Sarasso E, Forghieri M, Grassi A, Balestrino R, Basaia S, Tripodi C, Canu E, Volontè MA, Corbetta D, Filippi M, Agosta F. PMID: 42321233 [PubMed - as supplied by publisher]
	Molecular crosstalk between MAPK signaling and neuroprotective pathways in Parkinson's disease: from pathogenesis to therapeutic potential. Neuroscience Shalabi MG, Al-Kuraishy HM, Shokr MM, Batiha GE. PMID: 42320726 [PubMed - as supplied by publisher]
	Disease modification in advanced Parkinson's disease: a review and roadmap for paving the way for next-generation interventions. J Neural Transm (Vienna) Groppa S, Fasano A, Urso D, Yang X, Popescu B, Klivenyi P, van Laar T, Jost W, Garcia-Ruiz PJ, Bhidayasiri R, Outeiro TF. PMID: 42319427 [PubMed - as supplied by publisher]
	The role of energy deficit in autophagy failure in Parkinson's disease. Front Aging Neurosci Bosnjak M, Misirkic Marjanovic M, Kosic M, Mandic M, Vucicevic L, Paunovic V, Harhaji-Trajkovic L. PMID: 42318554 [PubMed]
	Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study. Front Neurol Chmiela T, Dulski J, Heckman MG, Fang ZJ, Wszolek ZK, Wilson JR. PMID: 42318251 [PubMed]
	A dual timeline of safinamide effects in Parkinson's disease: mechanistic rationale and clinical implications. Front Neurol Bhidayasiri R, Suansanae T. PMID: 42318242 [PubMed]
	Effect of 6S refined individualized nursing management in the perioperative period of Parkinson's disease patients undergoing deep brain stimulation. Front Neurol Luo Y, Guo F, Bai J, Li X, Bei J, Xing Y, Zhang F. PMID: 42318236 [PubMed]
	Acupuncture-Related Therapies as a Potential Adjuvant Option for Parkinson's Disease: Effects on Symptom Management, Medication Use, and Mortality. Parkinsons Dis Lee YS, Lee HG, Park HJ, Kwon S, Jang BH. PMID: 42317575 [PubMed]
	Prebiotics and SCFA Alleviate Parkinson's-Related Constipation: Results from a Randomized Controlled Trial. Neurol Ther Hegelmaier T, Duscha A, Desel C, Würtele LM, Peplinski J, Jauk D, Troisi R, Klietz M, Faissner S, Müller T, Haghikia A. PMID: 42315784 [PubMed - as supplied by publisher]
	Movement Through Time: The Evolution of Treatment for People With Parkinson Disease. J Neurol Phys Ther Ellis T. PMID: 42313921 [PubMed - indexed for MEDLINE]
	Status of Alzheimer's and Parkinson's Disease Detections and Treatments. ACS Chem Neurosci Nguyen PH, Derreumaux P. PMID: 42313891 [PubMed - as supplied by publisher]
	Movement Through Time: The Evolution of Treatment for People with Parkinson Disease. J Neurol Phys Ther Ellis T. PMID: 42313714 [PubMed - as supplied by publisher]

Articles 1 - 20 / 57855

Page 1 of 2893



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy